The Gene Therapy Review is assembling an editorial board in order to facilitate the exapnsion of this open resource, enabling peer review and ultimate listing on resources such as PubMed. If you are interested in participating in this growing project then please contact the associate editor; mvougiouka@genetherapyreview.com

Currently the board consists of:

Editor-in-Chief: Michael L Roberts, PhD

Dr Roberts has more than 15 year experience in the Gene Therapy Sector, graduating from Glasgow University with first class honours and receiving his PhD from Cambridge University (Magdalene). He has post-doctoral research experience at Royal Holloway and the National Hellenic Research Foundation as a Marie Curie Fellow. After serving on the board of Regulon and directing R&D, he founded Synpromics, where he is President and CEO.

Associate Editor: Maria Vougiouka, BSc

Ms Vougiouka has more than 10 years experience in the scientific publishing sector. She played a key role in setting up Gene Therapy Press, where she administered two peer-reviewed journal; Gene Therapy and Molecular Biology (GTMB) and Cancer Therapy. She also has accrued several years experience in the regulatory industry where she worked for Wyeth and Pfizer.

Editorial Board Members

Jani K Raty, PhD - Head of Information Management, Amsterdam Molecular Therapeutics, The Netherlands.

Pankaj Kumar, PhD - Post-Doctoral Research Associate, Binghampton University, NY, USA.

Ekaterina Semenova, PhD - Post-Doctoral Research Associate, UCL Institute of Child Health, London, UK.